Citius Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Outstanding from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Citius Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q3 2010 to Q3 2024.
  • Citius Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 7.25M shares, a 14.1% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 7.25M +893K +14.1% Sep 30, 2024 10-K 2024-12-27
Q2 2024 181M +21.9M +13.8% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 159M +12.7M +8.7% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 159M +12.8M +8.72% Dec 31, 2023 10-Q 2024-02-14
Q3 2023 6.35M -140M -95.7% Sep 30, 2023 10-K 2024-12-27
Q2 2023 159M +12.7M +8.71% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 146M +228K +0.16% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 146M +182K +0.12% Dec 31, 2022 10-Q 2023-02-10
Q3 2022 146M +232K +0.16% Sep 30, 2022 10-K 2023-12-29
Q2 2022 146M +150K +0.1% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 146M +11.4M +8.48% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 146M +90.5M +163% Dec 31, 2021 10-Q 2022-02-10
Q3 2021 146M +90.4M +163% Sep 30, 2021 10-K 2022-12-22
Q2 2021 146M +99.7M +215% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 135M +96.6M +254% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 55.6M +25.4M +84.2% Dec 31, 2020 10-Q 2021-02-11
Q3 2020 55.6M +26.6M +92.1% Sep 30, 2020 10-K 2021-12-15
Q2 2020 46.3M +24.2M +110% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 38.1M +19.4M +104% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 30.2M +12.4M +69.5% Dec 31, 2019 10-Q 2020-02-13
Q3 2019 28.9M +12.7M +78.6% Sep 30, 2019 10-K 2020-12-16
Q2 2019 22.1M +11.4M +107% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 18.6M +7.98M +74.8% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 17.8M +7.82M +78.4% Dec 31, 2018 10-Q 2019-02-14
Q3 2018 16.2M +7.85M +94.1% Sep 30, 2018 10-K 2019-12-16
Q2 2018 10.7M +5.62M +111% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 10.7M -64.8M -85.9% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 9.98M -64.1M -86.5% Dec 31, 2017 10-Q 2018-02-14
Q3 2017 8.35M +3.47M +71.2% Sep 30, 2017 10-K 2018-12-11
Q2 2017 5.06M -68M -93.1% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 75.5M +4.37M +6.14% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 74.1M +39.4M +114% Dec 31, 2016 10-Q 2017-02-14
Q3 2016 4.88M -29.2M -85.7% Sep 30, 2016 10-K 2017-12-13
Q2 2016 73M +39.8M +120% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 71.1M +39.6M +125% Mar 31, 2016 10-Q 2016-05-20
Q4 2015 34.7M +3.62M +11.6% Dec 31, 2015 10-Q 2016-02-12
Q3 2015 34.1M +4.09M +13.6% Sep 30, 2015 10-K 2016-12-23
Q2 2015 33.2M +15.2M +84.6% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 31.6M +13.6M +75.4% Mar 31, 2015 10-Q 2015-05-13
Q4 2014 31.1M +13.3M +75% Dec 31, 2014 10-Q 2015-02-17
Q3 2014 30M +12M +66.8% Sep 30, 2014 10-K 2015-12-14
Q2 2014 18M 0 0% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 18M 0 0% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 17.8M -243K -1.35% Dec 31, 2013 10-KT 2014-12-29
Q3 2013 18M 0 0% Sep 30, 2013 10-Q 2014-08-14
Q2 2013 18M 0 0% Jun 30, 2013 10-Q 2013-09-18
Q1 2013 18M 0 0% Mar 31, 2013 10-Q 2013-05-13
Q4 2012 18M 0 0% Dec 31, 2012 10-Q 2013-02-08
Q3 2012 18M 0 0% Sep 30, 2012 10-K 2014-02-06
Q2 2012 18M 0 0% Jun 30, 2012 10-Q 2012-08-17
Q1 2012 18M Mar 31, 2012 10-Q 2012-05-11
Q4 2011 18M Dec 31, 2011 10-Q 2012-02-14
Q3 2011 18M 0 0% Sep 30, 2011 10-K 2013-01-15
Q2 2011 18M Jun 30, 2011 10-Q 2011-08-26
Q3 2010 18M Sep 30, 2010 10-K 2012-01-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.